Sign in
4/A

Changes in Ownership

Inogen Inc Filed Acc 0001209191-21-067949

EVP, Finance, & CFO sold 8,702 shares at an average $40.16 ($349,508)

  • EVP, Finance, & CFO acquired 8,702 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Bauerlein Alison EVP, Finance, & CFO 2020-12-15 Option exercise +8,702 $16.62 $144,627 41,172 D: show line 1 in the form
Bauerlein Alison EVP, Finance, & CFO 2020-12-15 Sale −4,449 $39.44 $175,464 36,723 D: show line 2 in the form
Bauerlein Alison EVP, Finance, & CFO 2020-12-15 Sale −1,904 $40.42 $76,960 34,819 D: show line 3 in the form
Bauerlein Alison EVP, Finance, & CFO 2020-12-15 Sale −2,349 $41.33 $97,084 32,470 D: show line 4 in the form
Open-market sales · 8,702 sh · avg $40.16 · $349,508

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Bauerlein Alison EVP, Finance, & CFO 2020-12-15 Option exercise · Stock Option (Right to Buy) −8,702 0 D: show line 5 in the form
Loading xslF345X03/doc4a.xml…